Xylo Technologies Ltd. (XYLO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Xylo Technologies Ltd. (XYLO) has a cash flow conversion efficiency ratio of -0.008x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-120.00K) by net assets ($15.92 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See XYLO defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Xylo Technologies Ltd. - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Xylo Technologies Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Xylo Technologies Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Xylo Technologies Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BIRKS GROUP INC. A
F:2BG
|
N/A |
|
Intelligent Bio Solutions Inc.
NASDAQ:INBS
|
-0.831x |
|
Charan Insurance Public Company Limited
BK:CHARAN
|
0.003x |
|
Iqstel Inc
NASDAQ:IQST
|
-0.012x |
|
The Calmer Co International Ltd
AU:CCO
|
-6.608x |
|
Professional Diversity Network Inc
NASDAQ:IPDN
|
0.126x |
|
EXPLOITS DISCOVERY CORP.
F:634
|
-0.041x |
|
Plascar Participações Industriais S.A
SA:PLAS3
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Xylo Technologies Ltd. (2016–2024)
The table below shows the annual cash flow conversion efficiency of Xylo Technologies Ltd. from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Xylo Technologies Ltd. stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $17.59 Million | $-1.82 Million | -0.104x | +46.16% |
| 2023-12-31 | $32.44 Million | $-6.25 Million | -0.193x | -86.23% |
| 2022-12-31 | $54.69 Million | $-5.66 Million | -0.103x | -1.32% |
| 2021-12-31 | $51.43 Million | $-5.25 Million | -0.102x | +56.48% |
| 2020-12-31 | $26.19 Million | $-6.14 Million | -0.235x | +29.24% |
| 2019-12-31 | $8.13 Million | $-2.69 Million | -0.331x | +36.58% |
| 2018-12-31 | $8.08 Million | $-4.22 Million | -0.523x | +38.47% |
| 2017-12-31 | $5.51 Million | $-4.68 Million | -0.849x | +73.18% |
| 2016-12-31 | $2.92 Million | $-9.26 Million | -3.168x | -- |
About Xylo Technologies Ltd.
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endosc… Read more